Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study [PDF]
Frontiers in Immunology, 2020 BackgroundImmunogenicity of tumor necrosis factor alpha inhibitors (TNFis) has been recognized as an important problem that may cause loss of efficacy and adverse events such as infusion reactions.
Sinem Nihal Esatoglu +10 more
doaj +3 more sources
Surgical treatment of intestinal perforation in Behçet syndrome: anunusual presentation [PDF]
The Pan African Medical Journal, 2018 Behçet syndrome is a chronic, recurring, systemic disorder characterized by the histopathologic finding of nonspecific vasculitis in multiple organs.
Carla Sofia Vicente +1 more
doaj +3 more sources
Heat Shock Proteins in Behçet Syndrome [PDF]
Balkan Medical Journal, 2023 Behçet syndrome (BS) is a systemic vasculitis of unknown etiology that affects the skin, mucosa, joints, eyes, central nervous system, gastrointestinal system, arteries, and veins.
Aslı Kıymet Kireçtepe Aydın +1 more
doaj +2 more sources
Bilateral optic neuritis as an atypical presentation of juvenile Behcet syndrome: A case report [PDF]
eNeurologicalSciBehcet syndrome is a systemic vasculitis characterized by relapsing uveitis, oral aphthous, and genital ulcers. We present a rare case of a 14-year-old male with juvenile Behcet syndrome (JBS) presenting as bilateral optic neuritis with oral aphthous ...
Armin Adibi +4 more
doaj +2 more sources
Work productivity in Behçet syndrome [PDF]
EULAR Rheumatology OpenObjectives: Behçet syndrome (BS) is a multisystem vasculitis that is most active during young adulthood. We aimed to evaluate work productivity and stability in patients with BS and compare it with diseased and healthy controls (HCs) in a cross-sectional
Nergis Serin +4 more
doaj +2 more sources
Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT [PDF]
Frontiers in ImmunologyNeuro-Behçet syndrome (NBS) is a rare but detrimental neurological manifestation of the Behçet syndrome (BS) – a chronic multisystemic inflammatory disease.
Charlotte Schubert +14 more
doaj +2 more sources
Elucidating the Role of Neutrophils in the Inflammatory Response to Behcet Syndrome [PDF]
Journal of Inflammation ResearchYesim Ozguler,1,2 Sinem Nihal Esatoglu,1,2 Gulen Hatemi1,2 1Department of Internal Medicine, Division of Rheumatology, Cerrahpaşa Medical School, Istanbul University-Cerrahpaşa, Istanbul, Türkiye; 2Behçet’s Disease Research Center ...
Ozguler Y, Esatoglu SN, Hatemi G
doaj +2 more sources
Infantile Onset Haploinsufficiency of A20 Treated by Infliximab, a Case Report and Brief Review of Literature [PDF]
International Medical Case Reports JournalFarhad Salehzadeh, Faeze Babazadeh KhoeiPediatric Department, Bouali Children`s Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, IranCorrespondence: Farhad Salehzadeh, Professor of Pediatric Rheumatology, Pediatric Department, Bouali ...
Salehzadeh F, Babazadeh Khoei F
doaj +2 more sources
Behçet Disease with Generalized Polymorphous Cutaneous Lesions: A Case Report
International Journal of Dermatology and Venerology, 2022 Introduction:. Behçet disease is a chronic multisystem vasculitis disease, however generalized polymorphous cutaneous lesions are uncommon. Here, we reported a case of Behçet disease with multiple parts of the body and complex lesions, which may lead to ...
Li-Wei Wang +4 more
doaj +1 more source
Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study [PDF]
Intestinal Research, 2021 Background/Aims The safety and effectiveness of adalimumab was demonstrated in a phase 3 trial in Japanese patients with intestinal Behçet’s disease. The aim of this study was to evaluate the long-term safety and effectiveness of adalimumab in Japanese ...
Yasuo Suzuki +5 more
doaj +1 more source